Merck & Company Inc annual gross profit for fiscal TTM was $49.8 billion, an increase of 6.5% from $46.7 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | $49.8B | $46.7B | $49.0B | $44.0B | $41.9B | $35.1B | $27.9B | $27.1B | $28.8B | $27.2B | $25.8B | $24.6B | $25.5B | $27.1B | $30.8B | $31.2B | $27.6B | $18.4B | $18.3B | $18.1B | $16.6B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | $13.3B | $11.5B | $13.0B | $12.0B | $11.7B | $11.8B | $12.6B | $12.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRK metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MRK financial statements → Interactive MRK charts →
About TickerBase · Data methodology & sources